Skip to main content
S&P 5007,673.52-0.58%DOW52,786.07-1.18%NASDAQ26,421.41-0.32%BTC$78,446.00-0.81%ETH$2,485.04-0.14%GOLD$4,402.10-0.83%OIL$94.40+1.47%
Smart Investors Daily
CE

NASDAQ · CERT

Certara, Inc.

Healthcare · Medical - Healthcare Information Services

$7.94

Down-$0.20 (-2.52%)

Updated Sep 8, 2026, 9:52 PM

SID Score

4.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.42B
P/E ratio
177.53
Dividend yield
0.00%
52-week range
$4.45 – $8.89
Volume
1.27M
Avg. volume
2.12M

Price performance

CERT price history

1M range · 20 trading sessions · Daily adjusted prices

CERT closed at $7.94 after 20 trading sessions, down 1.61% for the selected period.

Last close
$7.94
Period change
-1.61%
Period low
$7.94
Period high
$8.73
Daily close
View OHLC price history
CERT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 4, 2026$8.02$8.05$7.905$7.941.27M
Sep 3, 2026$8.35$8.43$7.9923$8.132.13M
Sep 2, 2026$8.10$8.415$8.10$8.281.53M
Sep 1, 2026$8.215$8.285$8.065$8.102.48M
Aug 31, 2026$8.22$8.31$8.03$8.291.71M
Aug 28, 2026$8.38$8.48$8.315$8.352.06M
Aug 27, 2026$8.23$8.49$8.20$8.411.4M
Aug 26, 2026$8.12$8.24$8.045$8.221.15M
Aug 25, 2026$7.99$8.265$7.955$8.142.56M
Aug 24, 2026$8.43$8.46$7.88$7.962.3M
Aug 21, 2026$8.83$8.83$8.39$8.432.04M
Aug 20, 2026$8.405$8.885$8.36$8.732.7M
Aug 19, 2026$8.11$8.37$8.08$8.362.03M
Aug 18, 2026$8.00$8.10$7.9301$8.011.94M
Aug 17, 2026$7.95$8.058$7.865$8.004.65M
Aug 14, 2026$8.26$8.29$7.95$8.001.43M
Aug 13, 2026$8.00$8.21$7.855$8.155.42M
Aug 12, 2026$8.13$8.18$7.94$8.013.34M
Aug 11, 2026$8.08$8.225$8.02$8.132.36M
Aug 10, 2026$8.13$8.18$7.985$8.073.06M

Latest CERT news

The latest Smart Investors Daily articles mentioning CERT.

Stock researchCompany · Overview

CERT research

Overview

Company profile and research snapshot.

Company profile

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$13.00
Implied upside
—
Analysts
—
CERT recent ratings
DateFirmRatingTarget
Aug 5, 2026BarclaysEqual-Weight—
May 12, 2026BMO CapitalMarket Perform—
May 12, 2026Craig-HallumHold—
May 12, 2026Stephens & Co.Overweight—
May 12, 2026BarclaysEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 3, 2026

Cerrado Gold Closes $10 Million Strategic Private Placement with Eric Sprott

TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Cerrado Gold Inc. [TSX.V:CERT][OTCQX:CRDOF] ("Cerrado" or the "Company") is pleased to announce that it has closed the previously announced strategic non-brokered private placement financing (the "Private Placement") with Mr. Eric Sprott for aggregate gross proceeds of C$10 million. The Private Placement consisted of the issuance of 4,000,000 units of the Company (the "Units") to an entity owned and controlled by Mr. Sprott at a price of C$2.50 per Uni

Yahoo · Aug 31, 2026

Cerrado Gold Announces $10 Million Strategic Private Placement with Eric Sprott

TORONTO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Cerrado Gold Inc. [TSX.V:CERT][OTCQX:CRDOF] ("Cerrado" or the "Company") is pleased to announce that it has entered into an agreement for a strategic non-brokered private placement financing (the "Private Placement") with Mr. Eric Sprott for aggregate gross proceeds of C$10 million. The Private Placement will consist of 4,000,000 units of the Company (the "Units") at a price of C$2.50 per Unit. Each Unit will consist of one common share in the capital o

Yahoo · Aug 7, 2026

The Bull Case For Certara (CERT) Could Change Following Wider Q2 Loss And Leadership Shake-Up - Learn Why

In early August 2026, Certara reported second-quarter results showing slightly higher sales of US$93.27 million but a much larger net loss of US$55.27 million, alongside executive reshuffling including the departure of President and Chief Commercial Officer Leif Pedersen and the appointment of Julien Perrier as Chief Commercial Officer and Eric Jahn as Chief Information Officer. At the same time, Certara reaffirmed its 2026 revenue outlook while expanding its share repurchase authorization...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By